Jeffrey Oram - Oct 15, 2021 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director
Signature
/s/ Jeffrey Oram
Stock symbol
ALZN
Transactions as of
Oct 15, 2021
Transactions value $
$0
Form type
4
Date filed
10/18/2021, 05:00 PM
Previous filing
Sep 15, 2021
Next filing
Mar 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Options Exercise $0 +47.2K +1699.86% $0.00 50K Oct 15, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALZN Restricted Stock Grant Options Exercise $0 -47.2K -48.57% $0.00 50K Oct 15, 2021 Common Stock 47.2K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting of restricted stock
F2 Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc.
F3 The restricted stock grant was amended on October 13, 2021, such that 47,222 shares of restricted stock vested on October 15, 2021, and the remaining 50,000 shares of restricted stock shall vest on March 15, 2022. 2,778 shares previously vested on September 13, 2021.